This is a Validated Antibody Database (VAD) review about dog CCND1, based on 17 published articles (read how Labome selects the articles), using CCND1 antibody in all methods. It is aimed to help Labome visitors find the most suited CCND1 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
CCND1 synonym: G1/S-specific cyclin-D1

Invitrogen
mouse monoclonal (DCS-6)
  • western blot; mouse; 1:200
In order to study the role of Notch-dependent erroneous cell cycle reentry in neurodegeneration, Invitrogen CCND1 antibody (Thermo Fisher Scientific, MA5-12702) was used in western blot on mouse samples at 1:200. Cell Death Differ (2015) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig 4
In order to determine that decreased lipid synthesis in breast cancer cells and its association with acetylated-defective mutant of Ppary, Invitrogen CCND1 antibody (NeoMarker, Ab3) was used in western blot on human samples (fig 4). Oncotarget (2014) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:1000; fig 1e
In order to learn how active PI3K signaling is required for WNT signaling and distant metastasis in colon cancer through nuclear beta-catenin transcriptional activity, Invitrogen CCND1 antibody (Neomarkers, DCS-6) was used in western blot on human samples at 1:1000 (fig 1e). Oncotarget (2014) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig s1e
In order to study the antitumor properties and mechanistic functions of PD-0332991 in prostate cancer models, Invitrogen CCND1 antibody (Neomarkers, AB3) was used in western blot on human samples (fig s1e). Oncogene (2013) ncbi
mouse monoclonal (DCS-6)
  • western blot; mouse
In order to identify the effect of resveratrol on clonal expansion and terminal adipogenesis in 3T3-L1 preadipocytes, Invitrogen CCND1 antibody (Thermofisher, DCS-6) was used in western blot on mouse samples . J Gerontol A Biol Sci Med Sci (2013) ncbi
mouse monoclonal (DCS-6)
  • western blot; mouse; fig 1
In order to explore the contributions of hyperglycemia and p27(kip1) suppression on islet beta cell regeneration, Invitrogen CCND1 antibody (Thermo Fisher Scientific, DCS-6) was used in western blot on mouse samples (fig 1). Int J Endocrinol (2012) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig 1
In order to determine the expression of full-length and LMW cyclin E in bladder cancer cell lines and patient tumors, Invitrogen CCND1 antibody (Zymed Laboratories, clone AHF0082) was used in western blot on human samples (fig 1). Cell Cycle (2012) ncbi
mouse monoclonal (DCS-6)
  • immunocytochemistry; human; 1:100; fig 4
In order to study the immunohistochemical localization of CIP/KIP inhibitors, G1 cyclins D1, D3, E and p53 proteins in the rat term placenta, Invitrogen CCND1 antibody (Biosource, AHF0082) was used in immunocytochemistry on human samples at 1:100 (fig 4). Histochem Cell Biol (2011) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:1000; fig 5
In order to discuss targeting the Frizzled-7 receptor for treating hepatocellular carcinoma, Invitrogen CCND1 antibody (Thermo Scientific, MS-210-B0) was used in western blot on human samples at 1:1000 (fig 5). Mol Cancer (2011) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:250; fig 2
In order to investigate the cellular effects of chlorophyllin treatment, Invitrogen CCND1 antibody (Biosource, DCS-6) was used in western blot on human samples at 1:250 (fig 2). Int J Cancer (2009) ncbi
mouse monoclonal (DCS-6)
  • western blot; human
In order to screen for compounds that suppress cyclin D2 promoter transcription, Invitrogen CCND1 antibody (BioSource, DCS-6) was used in western blot on human samples . Blood (2009) ncbi
mouse monoclonal (DCS-6)
  • western blot; human
In order to examine if EGF-R contributes to the hydrocortisone and indomethacin-induced intestinal perforations of preterm infants, Invitrogen CCND1 antibody (NeoMarkers, DCS6) was used in western blot on human samples . Pediatr Res (2007) ncbi
mouse monoclonal (DCS-6)
  • western blot; rat; 1:150; fig 3
In order to study the mechanism of thrombin-induced apoptosis in cultured cortical neurons, Invitrogen CCND1 antibody (Biosource, AHF0082) was used in western blot on rat samples at 1:150 (fig 3). J Neurochem (2007) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; 1:500; fig 6
In order to study endogenous prolactin, Invitrogen CCND1 antibody (Neomarkers, MS-210-P1) was used in western blot on human samples at 1:500 (fig 6). J Steroid Biochem Mol Biol (2004) ncbi
mouse monoclonal (DCS-6)
  • western blot; rat; 1:200; loading ...; fig 1b
In order to study the role of STAT5 in transcriptional induction of the cyclin D2 gene and proliferation of rat pancreatic beta-cells, Invitrogen CCND1 antibody (Neo Markers, MS-215) was used in western blot on rat samples at 1:200 (fig 1b). Mol Endocrinol (2003) ncbi
mouse monoclonal (DCS-6)
  • western blot; human; fig 6
In order to study the mechanism by which rapamycin potentiates TGFbeta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells, Invitrogen CCND1 antibody (Neomarkers, DCS-6) was used in western blot on human samples (fig 6). Mol Cell Biol (2002) ncbi
mouse monoclonal (DCS-6)
  • immunohistochemistry - paraffin section; human; 1:500; fig 1
In order to discuss the use of CD5 to diagnose mantle cell lymphoma, Invitrogen CCND1 antibody (Neomarkers, clone DCS-6) was used in immunohistochemistry - paraffin section on human samples at 1:500 (fig 1). Am J Clin Pathol (2002) ncbi
Articles Reviewed
  1. Marathe S, Liu S, Brai E, Kaczarowski M, Alberi L. Notch signaling in response to excitotoxicity induces neurodegeneration via erroneous cell cycle reentry. Cell Death Differ. 2015;22:1775-84 pubmed publisher
  2. Tian L, Wang C, Hagen F, Gormley M, Addya S, Soccio R, et al. Acetylation-defective mutant of Pparγ is associated with decreased lipid synthesis in breast cancer cells. Oncotarget. 2014;5:7303-15 pubmed
  3. Ormanns S, Neumann J, Horst D, Kirchner T, Jung A. WNT signaling and distant metastasis in colon cancer through transcriptional activity of nuclear ?-Catenin depend on active PI3K signaling. Oncotarget. 2014;5:2999-3011 pubmed
  4. Comstock C, Augello M, Goodwin J, de Leeuw R, Schiewer M, Ostrander W, et al. Targeting cell cycle and hormone receptor pathways in cancer. Oncogene. 2013;32:5481-91 pubmed publisher
  5. Mitterberger M, Zwerschke W. Mechanisms of resveratrol-induced inhibition of clonal expansion and terminal adipogenic differentiation in 3T3-L1 preadipocytes. J Gerontol A Biol Sci Med Sci. 2013;68:1356-76 pubmed publisher
  6. Chen S, Fu S, Hsu S, Huang Y, Hsu B. Synergistic Effect of Hyperglycemia and p27(kip1) Suppression on Adult Mouse Islet Beta Cell Replication. Int J Endocrinol. 2012;2012:417390 pubmed publisher
  7. Akli S, Zhang X, Bondaruk J, Tucker S, Czerniak P, Benedict W, et al. Low molecular weight cyclin E is associated with p27-resistant, high-grade, high-stage and invasive bladder cancer. Cell Cycle. 2012;11:1468-76 pubmed publisher
  8. Korgun E, Unek G, Herrera E, Jones C, Wadsack C, Kipmen Korgun D, et al. Mapping of CIP/KIP inhibitors, G1 cyclins D1, D3, E and p53 proteins in the rat term placenta. Histochem Cell Biol. 2011;136:267-78 pubmed publisher
  9. Wei W, Chua M, Grepper S, So S. Soluble Frizzled-7 receptor inhibits Wnt signaling and sensitizes hepatocellular carcinoma cells towards doxorubicin. Mol Cancer. 2011;10:16 pubmed publisher
  10. Chimploy K, Díaz G, Li Q, Carter O, Dashwood W, Mathews C, et al. E2F4 and ribonucleotide reductase mediate S-phase arrest in colon cancer cells treated with chlorophyllin. Int J Cancer. 2009;125:2086-94 pubmed publisher
  11. Tiedemann R, Schmidt J, Keats J, Shi C, Zhu Y, Palmer S, et al. Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo. Blood. 2009;113:4027-37 pubmed publisher
  12. Kajanne R, Leppa S, Luukkainen P, Ustinov J, Thiel A, Ristimaki A, et al. Hydrocortisone and indomethacin negatively modulate EGF-R signaling in human fetal intestine. Pediatr Res. 2007;62:570-5 pubmed
  13. Rao H, Thirumangalakudi L, Desmond P, Grammas P. Cyclin D1, cdk4, and Bim are involved in thrombin-induced apoptosis in cultured cortical neurons. J Neurochem. 2007;101:498-505 pubmed
  14. Gutzman J, Miller K, Schuler L. Endogenous human prolactin and not exogenous human prolactin induces estrogen receptor alpha and prolactin receptor expression and increases estrogen responsiveness in breast cancer cells. J Steroid Biochem Mol Biol. 2004;88:69-77 pubmed
  15. Friedrichsen B, Richter H, Hansen J, Rhodes C, Nielsen J, Billestrup N, et al. Signal transducer and activator of transcription 5 activation is sufficient to drive transcriptional induction of cyclin D2 gene and proliferation of rat pancreatic beta-cells. Mol Endocrinol. 2003;17:945-58 pubmed
  16. Law B, Chytil A, Dumont N, Hamilton E, Waltner Law M, Aakre M, et al. Rapamycin potentiates transforming growth factor beta-induced growth arrest in nontransformed, oncogene-transformed, and human cancer cells. Mol Cell Biol. 2002;22:8184-98 pubmed
  17. Liu Z, Dong H, Gorczyca W, Tsang P, Cohen P, Stephenson C, et al. CD5- mantle cell lymphoma. Am J Clin Pathol. 2002;118:216-24 pubmed